127 related articles for article (PubMed ID: 36799779)
1. A commentary on "An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts".
Liu ZP; Dai HS; Zhang YQ; Yin XY; Chen ZY
Int J Surg; 2023 Jan; 109(1):1-2. PubMed ID: 36799779
[No Abstract] [Full Text] [Related]
2. An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts.
Li X; Zhai Z; Ding W; Chen L; Zhao Y; Xiong W; Zhang Y; Lin D; Chen Z; Wang W; Gao Y; Cai S; Yu J; Zhang X; Liu H; Li G; Chen T
Int J Surg; 2022 Sep; 105():106889. PubMed ID: 36084807
[TBL] [Abstract][Full Text] [Related]
3. A new scoring system to evaluate adjuvant chemotherapy for patients with T2N0M0 gastric cancer after D2 gastrectomy.
Xu Q; Kang WZ; Xiong JP; Shao XX; Li WK; Hu HT; Tian YT
World J Gastroenterol; 2022 Oct; 28(38):5626-5635. PubMed ID: 36304088
[TBL] [Abstract][Full Text] [Related]
4. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
Cheng X; Wu D; Xu N; Chen L; Yan Z; Chen P; Zhou L; Yu J; Cui J; Li W; Wang C; Feng W; Wei Y; Yu P; Du Y; Ying J; Xu Z; Yang L; Zhang Y
BMC Cancer; 2021 Jan; 21(1):56. PubMed ID: 33435909
[TBL] [Abstract][Full Text] [Related]
6. Impact of postoperative infectious complications on adjuvant chemotherapy administration after gastrectomy for advanced gastric cancer.
Tsujimoto H; Kouzu K; Sugasawa H; Nomura S; Ito N; Harada M; Sugihara T; Ishibashi Y; Kishi Y; Ueno H
Jpn J Clin Oncol; 2021 Mar; 51(3):379-386. PubMed ID: 33236062
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for elderly patients (aged 70 or older) with gastric cancer after a gastrectomy with D2 dissection: A single center experience in Korea.
Jo JC; Baek JH; Koh SJ; Kim H; Min YJ; Lee BU; Kim BG; Jeong ID; Cho HR; Kim GY
Asia Pac J Clin Oncol; 2015 Dec; 11(4):282-7. PubMed ID: 25856172
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy may be unnecessary for ypT0-2N0 gastric cancer patients after neoadjuvant chemotherapy and curative gastrectomy.
Shao X; Ma F; Kang W; Xiong J; Hu H; Li W; Xie Y; Tian Y
Chin Med J (Engl); 2023 Aug; 136(16):2002-2004. PubMed ID: 37365146
[No Abstract] [Full Text] [Related]
9. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
10. Risk Factors for Poor Compliance with Adjuvant S-1 Chemotherapy for Gastric Cancer: A Multicenter Retrospective Study.
Yamashita K; Kurokawa Y; Yamamoto K; Hirota M; Kawabata R; Mikami J; Masuzawa T; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2017 Sep; 24(9):2639-2645. PubMed ID: 28608116
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
[TBL] [Abstract][Full Text] [Related]
12. Palliative gastrectomy in patients with stage IV gastric cancer--our recent experience.
Lupaşcu C; Andronic D; Ursulescu C; Vasiluţă C; Raileanu G; Georgescu St; Niculescu D; Crumpei F; Târcoveanu E
Chirurgia (Bucur); 2010; 105(4):473-6. PubMed ID: 20941968
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for elderly patients with gastric cancer after D2 gastrectomy.
Jin Y; Qiu MZ; Wang DS; Zhang DS; Ren C; Bai L; Luo HY; Wang ZQ; Wang FH; Li YH; Xu RH
PLoS One; 2013; 8(1):e53149. PubMed ID: 23359796
[TBL] [Abstract][Full Text] [Related]
14. [Second malignancy after gastrectomy for early gastric cancer-is there any evidence that adjuvant chemotherapy for early gastric cancer causes a second malignancy ?].
Honda I; Kobayashi D; Fukumoto R; Matsushita H; Hattori M; Nagata M; Watanabe S
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1341-5. PubMed ID: 18701845
[TBL] [Abstract][Full Text] [Related]
15. Chemoresponse after non-curative gastrectomy for M1 gastric cancer.
Shin HB; Lee SH; Son YG; Ryu SW; Sohn SS
World J Surg Oncol; 2015 Jan; 13():13. PubMed ID: 25634223
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy provided survival benefit for stage T2N0 gastric cancer with high-risk factors.
Wang Z; Yan J; Hu W; Zhang J; Huo B
Neoplasma; 2018; 65(4):592-598. PubMed ID: 29940758
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Post-Gastrectomy Adjuvant S-1 Chemotherapy on Muscle Volume in Gastric Cancer Patients].
Iwazawa T; Kawanishi K; Fujita J; Takata A; Hirota M; Imamura H; Ikeda A; Hokonohara K; Yoneyama C; Kameyama A; Shinke G; Oshima K; Tanida T; Hatano H; Noda T; Komori T; Morita S; Akagi K; Dono K
Gan To Kagaku Ryoho; 2015 Aug; 42(8):957-60. PubMed ID: 26321709
[TBL] [Abstract][Full Text] [Related]
18. Prolonged adjuvant capecitabine chemotherapy improved survival of stage IIIA gastric cancer after D2 gastrectomy.
Feng WM; Tang CW; Guo HH; Bao Y; Fei MY
Biomed Pharmacother; 2015 May; 72():140-3. PubMed ID: 26054688
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive imaging evaluation of peritoneal recurrence and chemotherapy benefit in gastric cancer after gastrectomy: a multicenter study.
Sun Z; Wang W; Huang W; Zhang T; Chen C; Yuan Q; Chen Y; Zhou K; Han Z; Feng H; Chen H; Liang X; Hu Y; Yu J; Liu H; Yu L; Xu Y; Li G; Jiang Y
Int J Surg; 2023 Jul; 109(7):2010-2024. PubMed ID: 37300884
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
